MedPath

MEDIVANCE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Normothermia Protocol for Traumatic Brain Injury Patients

Conditions
Traumatic Brain Injury
First Posted Date
2011-05-17
Last Posted Date
2011-05-18
Lead Sponsor
Medivance, Inc.
Target Recruit Count
80
Registration Number
NCT01354509
Locations
🇺🇸

Mercy St John's Medical Center, St Louis, Missouri, United States

Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients

Phase 2
Completed
Conditions
Cardiac Arrest
First Posted Date
2006-01-26
Last Posted Date
2007-09-11
Lead Sponsor
Medivance, Inc.
Target Recruit Count
64
Registration Number
NCT00282373
Locations
🇺🇸

University of Arizona Medical Center, Tucson, Arizona, United States

🇺🇸

University of Colorado Health Science Center, Denver, Colorado, United States

🇺🇸

Johns Hopkins - Bayview Medical Center, Baltimore, Maryland, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.